{"id":58708,"date":"2026-02-18T08:38:25","date_gmt":"2026-02-18T12:38:25","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/ukraine-pursues-high-level-china-dialogue-fda-accepts-modernas-flu-vaccine-review\/58708\/"},"modified":"2026-02-18T08:38:25","modified_gmt":"2026-02-18T12:38:25","slug":"ukraine-pursues-high-level-china-dialogue-fda-accepts-modernas-flu-vaccine-review","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/ukraine-pursues-high-level-china-dialogue-fda-accepts-modernas-flu-vaccine-review\/58708\/","title":{"rendered":"Ukraine Pursues High-Level China Dialogue; FDA Accepts Moderna\u2019s Flu Vaccine Review"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Moderna<\/strong> (<a href=\"\/stock\/MRNA\">MRNA<\/a>) announced the <strong>US FDA<\/strong> has accepted its Biologics License Application for <strong>mRNA-1010<\/strong>, a seasonal influenza vaccine, with a <strong>PDUFA<\/strong> goal date of <strong>August 5, 2026<\/strong>.<\/li>\n<li>Ukraine is actively seeking a <strong>leaders-level dialogue<\/strong> with <strong>China<\/strong> to discuss peace efforts, according to Foreign Ministry spokesperson <strong>Heorhii Tykhyi<\/strong>.<\/li>\n<li>Kyiv and Beijing are currently planning <strong>ministry-level meetings<\/strong> to facilitate deeper bilateral engagement and address regional security issues.<\/li>\n<li><strong>Moderna\u2019s<\/strong> (<a href=\"\/stock\/MRNA\">MRNA<\/a>) revised regulatory strategy seeks <strong>full approval<\/strong> for adults aged <strong>50-64<\/strong> and <strong>accelerated approval<\/strong> for those <strong>65 and older<\/strong>.<\/li>\n<li>Shares of <strong>Moderna<\/strong> (<a href=\"\/stock\/MRNA\">MRNA<\/a>) rose approximately <em>2%<\/em> in early trading following the <strong>FDA&#39;s<\/strong> decision to proceed with the review.<\/li>\n<\/ul>\n<p>The <strong>US Food and Drug Administration (FDA)<\/strong> has officially initiated its review of <strong>Moderna&#39;s<\/strong> (<a href=\"\/stock\/MRNA\">MRNA<\/a>) investigational seasonal influenza vaccine, <strong>mRNA-1010<\/strong>. This milestone follows a <strong>Type A meeting<\/strong> where the company proposed a revised regulatory pathway after previously receiving a refusal-to-file letter. The <strong>FDA<\/strong> has set a <strong>Prescription Drug User Fee Act (PDUFA)<\/strong> action date for <strong>August 5, 2026<\/strong>, positioning the vaccine for potential availability during the <strong>2026\/2027 flu season<\/strong>.<\/p>\n<p><strong>Moderna<\/strong> (<a href=\"\/stock\/MRNA\">MRNA<\/a>) is seeking <strong>full approval<\/strong> for adults aged <strong>50 to 64<\/strong> and <strong>accelerated approval<\/strong> for those <strong>65 and older<\/strong>, the latter of which would require a post-marketing study. <em>Investors reacted positively to the news<\/em>, as the acceptance of the application signals a significant step in <strong>Moderna&#39;s<\/strong> effort to diversify its mRNA portfolio beyond COVID-19. The vaccine is also currently under regulatory review in <strong>Europe<\/strong>, <strong>Canada<\/strong>, and <strong>Australia<\/strong>.<\/p>\n<p>On the geopolitical front, Ukraine is intensifying its diplomatic outreach to <strong>China<\/strong>, expressing a strong interest in a <strong>leaders-level dialogue<\/strong>. Ukrainian Foreign Ministry spokesperson <strong>Heorhii Tykhyi<\/strong> confirmed on Wednesday that the government is working toward a high-profile meeting between President <strong>Volodymyr Zelenskyy<\/strong> and Chinese leader <strong>Xi Jinping<\/strong>. This push for top-tier engagement follows recent discussions at the <strong>Munich Security Conference<\/strong> where both nations signaled that the &quot;door to dialogue&quot; remains open.<\/p>\n<p>In the immediate term, Ukraine and <strong>China<\/strong> are planning a series of <strong>ministry-level meetings<\/strong> to lay the groundwork for further cooperation. <strong>Tykhyi<\/strong> emphasized that a direct dialogue with Beijing is &quot;very important,&quot; particularly regarding the implementation of a just peace and the protection of territorial integrity. <em>Diplomatic analysts suggest<\/em> that Kyiv is looking to leverage <strong>China&#39;s<\/strong> influence to pressure <strong>Russia<\/strong> toward a negotiated settlement as the conflict enters its fourth year.<\/p>\n<p>The planned meetings between foreign ministry officials are expected to cover a broad range of bilateral and regional international issues. Ukraine has also extended an invitation to Chinese Foreign Minister <strong>Wang Yi<\/strong> to visit the country to witness the impact of the ongoing war firsthand. While a specific timeline for a presidential summit has not been finalized, the move toward <strong>ministry-level<\/strong> talks indicates a <em>dynamic intensification<\/em> of relations between the two capitals.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Moderna (MRNA) announced the US FDA has accepted its Biologics License Application for mRNA-1010, a seasonal influenza vaccine, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[1327,4824,5042,5227,5833,5998,6015,9632],"class_list":["post-58708","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-china","tag-geopolitics","tag-ukraine","tag-healthcare","tag-fda","tag-mrna-stock-mrna","tag-moderna","tag-pdufa"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/58708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=58708"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/58708\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=58708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=58708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=58708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}